Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13129831 | 0.87 | LGALS8 (0.44) | CYP3A4LMNAALDH1A1LGALS8 | |
| SCHEMBL1491873 | 0.86 | SLC5A2 (0.42) | CYP3A4CYP2D6NPC1RAB9A | |
| SCHEMBL7955544 | 0.83 | NT5E (0.47) | CYP3A4SMN1; SMN2KMT2ALMNAALDH1A1 | |
| SCHEMBL15975387 | 0.83 | ALDH1A1 (0.44) | CYP3A4KMT2ALMNAALDH1A1CYP2C9 | |
| SCHEMBL13129783 | 0.83 | ALDH1A1 (0.44) | CYP3A4KMT2ALMNAALDH1A1CYP2C9 | |
| SCHEMBL13129878 | 0.83 | ALDH1A1 (0.44) | CYP3A4KMT2ALMNAALDH1A1CYP2C9 | |
| SCHEMBL12757249 | 0.82 | CYP3A4 (0.38) | CYP3A4CYP2D6KMT2ALMNAMAPK1 | |
| SCHEMBL1491946 | 0.81 | FGF2 (0.44) | CYP3A4CYP2D6LMNAALDH1A1CYP2C9 | |
| SCHEMBL14672600 | 0.81 | FGF2 (0.42) | SMN1; SMN2KMT2ANPC1RAB9ATP53 | |
| SCHEMBL22073057 | 0.80 | NT5E (0.49) | CYP3A4CYP2D6MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7901687-B2 | Antibodies for the detection of Bacillus anthracis and vaccine against B. anthracis infections | ETH ZURICH (CH) | 2011-03-08 | — | — | US | disclosed |
| US-20090155299-A1 | Antibodies for the Detection of Bacillus Anthracis and Vaccine Against B. Anthracis Infections | SCHWEIZERISCHES TROPENINSTITUT (CH) | 2009-06-18 | — | — | US | disclosed |
| EP-2012821-A2 | ANTIBODIES FOR THE DETECTION OF BACILLUS ANTHRACIS AND VACCINE AGAINST B. ANTHRACIS INFECTIONS | ETH Zürich (CH) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007125089-A2 | ANTIBODIES FOR THE DETECTION OF BACILLUS ANTHRACIS AND VACCINE AGAINST B. ANTHRACIS INFECTIONS | ETH Zürich (CH) | 2007-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090155299-A1 | Antibodies for the Detection of Bacillus Anthracis and Vaccine Against B. Anthracis Infections | ANTXR2, CERT1, DAD1 | CYP3A4 3175/4885CYP2D6 3116/4885SMN1; SMN2 2630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.